Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

life sciences

- PMLiVE

Ipsen acquires OctreoPharm to boost its oncology presence

Will aid the development of its approach to neuroendrocrine tumours

- PMLiVE

BIA says action plan could quadruple R&D output by 2025

Claims it could rank the UK in the global top three largest biotech clusters

- PMLiVE

GSK to establish US R&D centre for vaccines

Facility will be based in Rockville, Maryland

- PMLiVE

Covance and Sihuan Pharma partner on portfolio development

Will collaborate on preclinical and clinical stages

- PMLiVE

IMI picks Ipsen’s Marc de Garidel to chair governing board

He takes over from former UCB CEO Roch Doliveux

- PMLiVE

UK Budget welcomed by life science industry

New measures include a £20m health funding boost for the north of England

France flag

French pharma growth restricted by generics

New analysis finds country’s market value will grow only modestly in the coming years

- PMLiVE

UK CROs to offer drug discovery services to Nordic businesses

Will head to Copenhagen in March for market visit

- PMLiVE

Products over pipeline in Pfizer’s acquisition targets, hints CEO

Sale forecasts for 2015 are down by up to $5bn compared to last year

- PMLiVE

Novartis signs stem cell research pact with Intellia

Will work with the biotech start-up on creating new treatments

- PMLiVE

FDA approves Ipsen drug to treat rare tumours

Green light for Somatuline Depot in cancer of the neuroendocrine system

- PMLiVE

US R&D hit in GSK’s latest cost-cutting round

CRO Parexel rumoured to contract “up to 450” GSK employees

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links